Ukraine Passed a Law Banning Registration of the COVID Vaccine Developed by Russia

January 29, 2021

KYIV, Ukraine — The parliament of Ukraine has passed a law banning registration of the coronavirus vaccine developed by Russia.

The vaccine, called Sputnik V, has been registered for use in 11 countries as well as in Russia. The parliament on Friday approved registration for vaccines used in the United States, China, Japan and the European Union, among other countries, but specifically excluded vaccines developed by “the aggressor state.”

Ukraine’s relations with Russia plunged after the 2014 Russian annexation of Crimea and the continuing conflict in the country’s east with Russia-backed separatists. Ukraine’s underfunded medical system has been hit hard by the coronavirus. The country of 44 million has recorded more than 1.2 million infections and more than 22,000 confirmed deaths.


ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.


TNΗ’s Happenings of the Week by Eraklis Diamataris

NEW YORK – The National Herald’s Happenings of the Week as have been reported at the print and digital editions of TNH and presented by the TNH Editor Eraklis Diamataris.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.